MDR & ISO 10993-1: How to Navigate Preclinical Device Testing

Posted by Rachel Callender on February 19, 2019

Medical Design Briefs online recently featured an article written by Sandi Schaible, Senior Director of Analytical Chemistry and Regulatory Toxicology at WuXi AppTec, expert in re-writing ISO 10993-18 as part of TC 194 / Working Group 14.

Read More

Topics: Contract Research Organization, Medical Device, Leachables, Preclinical Safety, Extractables, E & L, Regulatory, Regulatory Expertise, regulatory consultants, ISO 10993-1, MDR

ISO 10993-1: The Importance of Chemical Characterization

Posted by Rachel Callender on January 16, 2019

Think recent regulatory changes to ISO 10993-1 are impacting biocompatibility programs? Think again! Our Director of Analytical Chemistry, and International Delegate for ISO 10993 part 18, Sandi Schaible explains why chemical characterization should be the driver behind your biocompatibility testing plan.

Read More

Topics: Contract Research Organization, Medical Device, Leachables, Preclinical Safety, Extractables, E & L, Regulatory, Regulatory Expertise, regulatory consultants, ISO 10993-1, MDR

A Regulatory Consultant's Guide to ISO 10993 Updates Webinar

Posted by Rachel Callender on January 15, 2019

With changes to ISO 10993, chemical testing is more important than ever to support a medical device’s safety for market. Medical device manufacturers can no longer rely on biocompatibility testing alone to obtain regulatory approval.

Read More

Topics: Contract Research Organization, Medical Device, Leachables, Preclinical Safety, Extractables, E & L, Regulatory, Regulatory Expertise, regulatory consultants, ISO 10993-1, MDR

WuXi AppTec to Exhibit at DeviceTalks West, Costa Mesa, California

Posted by Rachel Callender on November 27, 2018

Visit the WuXi AppTec exhibitor booth #206 at DeviceTalks West, December 11-12, 2018, to learn how we work as a seamless extension of your team and develop a comprehensive program that will meet the endpoints you need to support your products’ safety.

Read More

Topics: E & L, Regulatory, hemocompatibility, Technical Expertise, Regulatory Expertise, histopathology, regulatory consultants, ISO 10993-1, MDR

Product Adoption for Sterilization Validation

Posted by Jill Warren, Technical Specialist on October 16, 2018

When your product has had a material change, a component added, or a new size developed, does this necessarily mean you must complete the sterilization validation of each?

There is another option:  product adoption.

WuXi AppTec Technical Experts answer common questions about product adoption when completing a sterilization validation.  The question to be answered is - whether or not to validate independently or adopt into a family?

Read More

Topics: Medical Device, Technical Expertise, Bioburden, Regulatory Expertise, Sterilization Validation

Poor Extraction Methods Can Impact Study Results

Posted by Dan Fowler, Principal Scientist on October 09, 2018

When planning a cleaning validation study for your medical device, a validated extraction method is one requirement.

The purpose of an extraction process is to recover any residual soils from the medical device or testing substrate and then quantify those residuals for specific test markers such as protein, hemoglobin or carbohydrates.

Read More

Topics: Medical Device, Technical Expertise, Reprocessing, Regulatory Expertise

wuxi apptec to exhibit at devicetalks boston

Posted by Rachel Callender on October 04, 2018

Visit the WuXi AppTec exhibitor booth #513 at DeviceTalks Boston, which takes place Oct. 8-10, 2018. WuXi AppTec works as a seamless extension of your team to develop a comprehensive program that will meet the endpoints you need to support your product’s safety.

Read More

Topics: E & L, Regulatory, hemocompatibility, Technical Expertise, Regulatory Expertise, histopathology, regulatory consultants, ISO 10993-1

WuXi AppTec Technical Experts at the American Association of Tissue Banks Expo, Booth #49

Posted by Britney Bartel, Marketing Manager on September 18, 2018

WuXi AppTec, a longtime member of the AATB, returns for the 42nd Annual Meeting, October 9-12, 2018.

The AATB annual meeting, held in Dallas, Texas, this year, encompasses a vast array of continuing education classes, breakout sessions and an expo. The meeting brings together suppliers, manufacturers and end users within the tissue-product ecosystem.

Read More

Topics: Medical Device, Technical Expertise, Contract Manufacturing, AATB Accreditation, Aseptic Technique, Regulatory Expertise, ISO 10993-1

Register Now for the PDA Chapter Dinner and Biocompatibility Presentation

Posted by Rachel Callender on September 17, 2018

WuXi AppTec Associate Director of Regulatory Toxicology Vanessa Haase, PhD, will present on biocompatibility testing as part of biological evaluation and ISO 10993.

Read More

Topics: E & L, Regulatory, hemocompatibility, Technical Expertise, Regulatory Expertise, histopathology, regulatory consultants, ISO 10993-1

WuXi AppTec to Present Case Study: Enhancing Biocompatibility Testing via Device-Specific Chemical Analysis

Posted by Britney Bartel, Marketing Manager on September 11, 2018

Associate Director of Regulatory Toxicology, Dr. Vanessa Haase, will present the case study at the Q1 Productions Medical Device Sterilization conference on September 24, 2018.

The most recent version of ISO 10993 Part 1, published in August 2018, emphasizes the need for biological evaluations to begin with chemical characterization. In this case study, Dr. Haase outlines a risk-based approach to device preclinical safety in accordance with ISO 10993. The case study, which features a blood-contacting device, summarizes chemical characterization, toxicological risk assessment and a biocompatibility test strategy for evaluating the relevant biological end points. Dr. Haase will speak at 11:15 am on September 24.

Read More

Topics: Medical Device, Technical Expertise, Regulatory Expertise, ISO 10993-1